148 related articles for article (PubMed ID: 20737625)
1. Kinetics of aspartic acid isomerization and enantiomerization in model aspartyl tripeptides under forced conditions.
Conrad U; Fahr A; Scriba GK
J Pharm Sci; 2010 Oct; 99(10):4162-73. PubMed ID: 20737625
[TBL] [Abstract][Full Text] [Related]
2. Capillary electrophoretic study of the degradation pathways and kinetics of the aspartyl model tetrapeptide Gly-Phe-Asp-GlyOH in alkaline solution.
Brückner C; Imhof D; Scriba GK
J Pharm Biomed Anal; 2013 Mar; 76():96-103. PubMed ID: 23298912
[TBL] [Abstract][Full Text] [Related]
3. Isomerization and epimerization of the aspartyl tetrapeptide Ala-Phe-Asp-GlyOH at pH 10-A CE study.
Brückner C; Bunz SC; Imhof D; Neusüss C; Scriba GK
Electrophoresis; 2013 Sep; 34(18):2666-73. PubMed ID: 23533053
[TBL] [Abstract][Full Text] [Related]
4. Degradation kinetics of an aspartyl-tripeptide-derived diketopiperazine under forced conditions.
Brückner C; Fahr A; Imhof D; Scriba GK
J Pharm Sci; 2012 Nov; 101(11):4178-90. PubMed ID: 22899465
[TBL] [Abstract][Full Text] [Related]
5. Capillary electrophoresis analysis of hydrolysis, isomerization and enantiomerization of aspartyl model tripeptides in acidic and alkaline solution.
De Boni S; Scriba GK
J Pharm Biomed Anal; 2007 Jan; 43(1):49-56. PubMed ID: 16846713
[TBL] [Abstract][Full Text] [Related]
6. Identification of degradation products of aspartyl tripeptides by capillary electrophoresis-tandem mass spectrometry.
De Boni S; Neusüss C; Pelzing M; Scriba GK
Electrophoresis; 2003 Mar; 24(5):874-82. PubMed ID: 12627450
[TBL] [Abstract][Full Text] [Related]
7. Capillary electrophoresis analysis of the degradation of the aspartyl tripeptide Phe-Asp-GlyOH at pH 2.0 and 7.4 under forced conditions.
Conrad U; Taichrib A; Neusüss C; Scriba GK
J Pharm Biomed Anal; 2010 Feb; 51(3):640-8. PubMed ID: 19875263
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aspartyl peptide degradation products by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry.
De Boni S; Oberthür C; Hamburger M; Scriba GK
J Chromatogr A; 2004 Jan; 1022(1-2):95-102. PubMed ID: 14753775
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the competitive reactions of isomerization and peptide bond cleavage at l-α- and d-β-aspartyl residues in an αA-crystallin fragment.
Aki K; Okamura E
J Pept Sci; 2017 Jan; 23(1):28-37. PubMed ID: 27905156
[TBL] [Abstract][Full Text] [Related]
10. A quantitative analysis of spontaneous isoaspartate formation from N-terminal asparaginyl and aspartyl residues.
Güttler BH; Cynis H; Seifert F; Ludwig HH; Porzel A; Schilling S
Amino Acids; 2013 Apr; 44(4):1205-14. PubMed ID: 23344882
[TBL] [Abstract][Full Text] [Related]
11. Determination of rate constants for β-linkage isomerization of three specific aspartyl residues in recombinant human αA-crystallin protein by reversed-phase HPLC.
Sadakane Y; Fujii N; Nakagomi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(29):3240-6. PubMed ID: 21470922
[TBL] [Abstract][Full Text] [Related]
12. The role of the cyclic imide in alternate degradation pathways for asparagine-containing peptides and proteins.
Dehart MP; Anderson BD
J Pharm Sci; 2007 Oct; 96(10):2667-85. PubMed ID: 17518358
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of isomerization and inversion of aspartate 58 of αA-crystallin peptide mimics under physiological conditions.
Aki K; Fujii N; Fujii N
PLoS One; 2013; 8(3):e58515. PubMed ID: 23505525
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous racemization and isomerization at specific aspartic acid residues in alpha B-crystallin from the aged human lens.
Fujii N; Ishibashi Y; Satoh K; Fujino M; Harada K
Biochim Biophys Acta; 1994 Feb; 1204(2):157-63. PubMed ID: 8142454
[TBL] [Abstract][Full Text] [Related]
15. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
Geiger T; Clarke S
J Biol Chem; 1987 Jan; 262(2):785-94. PubMed ID: 3805008
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of stereoisomers and isoforms of a tryptic heptapeptide fragment of human growth hormone and analysis by reverse-phase HPLC and capillary electrophoresis.
Vinther A; Holm A; Høeg-Jensen T; Jespersen AM; Klausen NK; Christensen T; Sørensen HH
Eur J Biochem; 1996 Jan; 235(1-2):304-9. PubMed ID: 8631346
[TBL] [Abstract][Full Text] [Related]
17. Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.
Kuang J; Tao Y; Song Y; Chemmalil L; Mussa N; Ding J; Li ZJ
Anal Bioanal Chem; 2021 Mar; 413(8):2113-2123. PubMed ID: 33543314
[TBL] [Abstract][Full Text] [Related]
18. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
Oliyai C; Borchardt RT
Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
[TBL] [Abstract][Full Text] [Related]
19. Quantification of structural alterations of L-Asp and L-Asn residues in peptides related to neuronal diseases by reversed-phase high-performance liquid chromatography.
Sadakane Y; Konoha K; Kawahara M; Nakagomi K
Chem Biodivers; 2010 Jun; 7(6):1371-9. PubMed ID: 20564556
[TBL] [Abstract][Full Text] [Related]
20. Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides.
Oliyai C; Borchardt RT
Pharm Res; 1994 May; 11(5):751-8. PubMed ID: 8058648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
